Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Goldman Sachs Upgrades Medtronic to Neutral, Raises Price Target to $111

Author: Benzinga Newsdesk | November 19, 2025 06:47am

Goldman Sachs analyst David Roman upgrades Medtronic (NYSE:MDT) from Sell to Neutral and raises the price target from $81 to $111.

Posted In: MDT